- Mexican authorities to seal secret tunnel on US border
- Vaccine misinformation: a lasting side effect from Covid
- Indian court finds man guilty in notorious hospital rape case
- TikTok's journey from fun app to US security concern
- The video games bedeviling Elon Musk
- Gamers tear into Musk for 'faking' video game prowess
- Global equities rally, pushing London and Frankfurt to new records
- US grounds SpaceX's Starship after fiery mid-air explosion
- US to tighten trade rules to hit low-cost China shipments
- US grounds SpaceX's Starship rocket pending probe
- IMF raises global growth outlook and flags rising economic divergence
- London, Frankfurt hit record highs as global equities rally
- Pompeii reveals 'impressive' bath complex
- EU deepens probe into X after Musk outbursts
- London stock market hits record high as global equities rally
- 2024 saw fastest-ever annual rise in CO2 levels: UK weather service
- 'No money': gloom on Beijing streets as economic growth slows
- Nintendo shares tumble as Switch 2 teaser disappoints
- Apple sidelines AI news summaries due to errors
- China says population fell for third year in a row in 2024
- Asian traders give mixed reaction as China's economic growth slows
- Chinese economic growth among slowest in decades
- 'Damaging' AI porn scandal at US school scars victims
- Nintendo shares tumble as Switch 2 preview disappoints
- SpaceX catches Starship booster again, but upper stage explodes
- SpaceX catches Starship booster but upper stage explodes
- Hypertec Cloud Partners With Potentia to Power Sustainable AI Cloud Expansion With Additional 480MW of Balanced Capacity Across North America
- Insurance access for US homeowners with higher climate risks declines
- Wall Street rally loses steam as European luxury shares advance
- China set to post sluggish growth as doldrums deepen
- US braces for freezing weather fueled by polar vortex
- Musk's Starship set for launch after Bezos orbital triumph
- Surf star Slater pays tribute as Quiksilver co-founder Green dies
- Teen kills fellow student teacher at Slovak school
- LIV Golf sign United States broadcast deal with Fox Sports
- Slovak entrepreneur funding rescue of German flying taxi startup
- French researchers aim to ease X refugees' path with 'HelloQuitX'
- China property giant Vanke's CEO 'taken away' by police: report
- Oil giant BP cuts thousands of jobs to slash costs
- EU announces 120 mn euros in Gaza aid after ceasefire
- Nepal's top court bars infrastructure in protected areas
- Stock markets jump as inflation worries ease
- China to probe US chips over dumping, subsidies
- India's outcast toilet cleaners keeping Hindu festival going
- Apple loses top spot in China smartphone sales to local rivals
- Sri Lanka signs landmark $3.7 bn deal with Chinese state oil giant
- Blue Origin's New Glenn rocket blasts into orbit for first time
- UK economy rebounds but headwinds remain for govt
- Stocks follow Wall St higher on welcome US inflation data
- Blue Origin's New Glenn rocket blasts off in first launch, reaches orbit
What is microRNA? Nobel-winning discovery explained
The Nobel Prize in Medicine was awarded on Monday to two US scientists for discovering microRNA, a previously unknown type of genetic switch which is hoped can pave the way for new medical breakthroughs.
But while several treatments and tests are under development using microRNAs against cancer, heart disease, viruses and other illnesses, none have actually yet reached patients.
And the world paid little attention when the new Nobel laureates Victor Ambros and Gary Ruvkun revealed their discovery decades ago, thinking it was just "something weird about worms", Cambridge University geneticist Eric Miska told AFP.
Here is an explainer about how exactly these tiny genetic switches work inside our bodies.
- What is microRNA? -
Each cell in the human body has the same set of instructions, called DNA. Some turn into brain cells, while others become muscles.
So how do the cells know what to become? The relevant part of the DNA's instructions is pointed to via a process called gene regulation.
Ribonucleic acid (RNA) normally serves as a messenger. It delivers the instructions from the DNA to proteins, which are the building blocks of life that turn cells into brains -- or muscles.
Miska gave the example of the messenger RNA vaccines rolled out against Covid-19 during the pandemic, which insert a message with new instructions to build proteins that block viruses.
But the two new Nobel winners Ambros and Ruvkun discovered a whole new type of gene regulator that had previously been overlooked by science.
Rather than being the messenger which relays information, microRNA instead acts as a switch to turn other genes off and on.
"This was a whole new level of control that we had totally missed," said Miska, who has worked on microRNA for two decades, including with the new Nobel laureates.
"The discovery of microRNAs brought an additional level of complexity by revealing that regions that were thought to be non-coding play a role in gene regulation," French researcher Benoit Ballester told AFP.
- What did the Nobel winners do? -
Back in the 1980s, Ambros and Ruvkun had been working separately on how genes interact in one-millimetre-long roundworms called C.elegans.
When they compared their work, it led to the discovery of microRNA. Ambros revealed the finding in a 1993 paper.
"Nobody really paid much attention," Miska said, explaining that most scientists at the time thought it only applied to worms.
Then in 2000, Ruvkun published research showing that microRNA is present right across the animal kingdom, including in humans and even some viruses.
"This was not just something weird that worms do, but in fact all animals and plants are totally dependent for development and normal function on them," Miska said.
More than a thousand genes that respond to microRNAs are now believed to be in the human body.
- How could this help us? -
There are numerous new treatments and tests using microRNA that are undergoing trials but none have been made widely available.
"Though there are no very clear applications available yet in microRNAs, understanding them, knowing that they exist, understanding their counter-regulatory networks, is always the first step," the Karolinska Institute's Gunilla Karlsson Hedestam told journalists in Stockholm.
MicroRNAs are particularly promising for fighting cancer because some of these switches "act as a tumour suppressor, so they put a brake on cells dividing inappropriately," Miska said.
Others, meanwhile, induce "cells to divide, which can lead to cancer", he added.
Because many viruses use microRNAs, several antiviral drugs are at varying stages of development, including for hepatitis C.
One complicating factor has been that microRNAs can be unstable.
But scientists also hope they can be used as a test called a "biomarker", which could reveal what type of cancer a patient could be suffering from, for example.
- What next? -
It also appears probable that microRNAs could be involved in the evolution of our species, Miska said.
While human brains are difficult to study, Miska hoped future research will discover more.
H.Cho--CPN